UK Nurse's Death Sparks Debate on Safety of Weight-Loss Jabs
Originally Published 1 year ago — by The Guardian
A UK nurse's death has been linked to the weight-loss drug tirzepatide, marketed as Mounjaro, which she obtained online and used before experiencing severe health issues. Her death certificate cites multiple organ failure and pancreatitis, with the drug noted as a contributing factor. The drug, approved in the UK in 2023, is under scrutiny, though authorities maintain its benefits outweigh risks. The incident raises concerns as the UK plans a trial to use tirzepatide to aid unemployed individuals in returning to work.